Board Certified Ophthalmologist FREE Glaucoma Management Questions and Answers 2

Question 1

A patient with primary open-angle glaucoma on maximum tolerated medical therapy continues to show progressive visual field loss. What is the most appropriate next step in management?

Accepted Answer

Trabeculectomy

Answer

Repeat visual field testing in 6 months

Answer

Add a fourth topical medication

Answer

Laser peripheral iridotomy

Question 2

Which class of glaucoma medications works by decreasing aqueous humor production through inhibition of carbonic anhydrase?

Accepted Answer

Dorzolamide

Answer

Latanoprost

Answer

Brimonidine

Answer

Pilocarpine

Question 3

A 55-year-old presents with acute angle-closure glaucoma. After initial medical management lowers the IOP, what definitive treatment should be performed?

Accepted Answer

Laser peripheral iridotomy

Answer

Trabeculectomy

Answer

Selective laser trabeculoplasty

Answer

Goniotomy

Question 4

Which visual field defect is most characteristic of early glaucomatous damage?

Accepted Answer

Nasal step

Answer

Homonymous hemianopia

Answer

Bitemporal hemianopia

Answer

Central scotoma

Question 5

What is the primary mechanism of action of selective laser trabeculoplasty (SLT) in lowering intraocular pressure?

Accepted Answer

Stimulating biological remodeling of trabecular meshwork cells

Answer

Creating thermal burns in the trabecular meshwork

Answer

Increasing uveoscleral outflow

Answer

Decreasing aqueous humor production

Question 6

In a patient with pseudoexfoliation glaucoma, which finding on gonioscopy is most characteristic?

Accepted Answer

Sampaolesi line

Answer

Peripheral anterior synechiae covering 360 degrees

Answer

Neovascularization of the angle

Answer

Angle recession

A patient with primary open-angle glaucoma on maximum tolerated medical therapy continues to show progressive visual field loss.What is the most appropriate next step in management?

A patient with primary open-angle glaucoma on maximum tolerated medical therapy continues to show progressive visual field loss.
What is the most appropriate next step in management?